SM-Youtube

Year	Number of Results
1991	2
1992	20
1993	29
1994	28
1995	23
1996	19
1997	21
1998	25
1999	21
2000	27
2001	30
2002	52
2003	78
2004	84
2005	134
2006	96
2007	77
2008	69
2009	59
2010	66
2011	81
2012	55
2013	61
2014	54
2015	46
2016	49
2017	44
2018	46
2019	38
2020	33
2021	30
2022	22
2023	14
2024	10

1

Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma.

Eskian M, Khorasanizadeh M, Zinzani PL, Illidge TM, Rezaei N. Eskian M, et al. Int Rev Immunol. 2019;38(2):79-91. doi: 10.1080/08830185.2019.1588266. Epub 2019 Mar 31. Int Rev Immunol. 2019. PMID: 30931651 Review.

2

Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles.

Leichner PK, Kwok CS. Leichner PK, et al. Med Phys. 1993 Mar-Apr;20(2 Pt 2):529-34. doi: 10.1118/1.597048. Med Phys. 1993. PMID: 8492761 Review.

3

Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite".

Arina A, Gutiontov SI, Weichselbaum RR. Arina A, et al. Clin Cancer Res. 2020 Jun 15;26(12):2777-2782. doi: 10.1158/1078-0432.CCR-19-2034. Epub 2020 Feb 11. Clin Cancer Res. 2020. PMID: 32047000 Free PMC article. Review.

4

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth.

Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. Morgenstern A, et al. Curr Radiopharm. 2018;11(3):200-208. doi: 10.2174/1874471011666180502104524. Curr Radiopharm. 2018. PMID: 29732998 Free PMC article. Review.

5

Comparison of residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--Monte Carlo simulation studies.

He B, Wahl RL, Du Y, Sgouros G, Jacene H, Flinn I, Frey EC. He B, et al. IEEE Trans Med Imaging. 2008 Apr;27(4):521-30. doi: 10.1109/TMI.2007.908131. IEEE Trans Med Imaging. 2008. PMID: 18390348 Free PMC article.

6

Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.

Ferrer L, Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Le Gouill S, Wegener WA, Goldenberg DM, Bardiès M. Ferrer L, et al. Cancer. 2010 Feb 15;116(4 Suppl):1093-100. doi: 10.1002/cncr.24797. Cancer. 2010. PMID: 20127958 Free article.

7

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Goldenberg DM, Chang CH, Sharkey RM, Rossi EA, Karacay H, McBride W, Hansen HJ, Chatal JF, Barbet J. Goldenberg DM, et al. Eur J Nucl Med Mol Imaging. 2003 May;30(5):777-80. doi: 10.1007/s00259-002-1089-6. Epub 2003 Feb 6. Eur J Nucl Med Mol Imaging. 2003. PMID: 12574971 No abstract available.

8

Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--patient studies.

He B, Wahl RL, Sgouros G, Du Y, Jacene H, Kasecamp WR, Flinn I, Hammes RJ, Bianco J, Kahl B, Frey EC. He B, et al. Med Phys. 2009 May;36(5):1595-601. doi: 10.1118/1.3100265. Med Phys. 2009. PMID: 19544775 Free PMC article. Clinical Trial.

9

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Paganelli G, Chinol M. Paganelli G, et al. Eur J Nucl Med Mol Imaging. 2003 May;30(5):773-6. doi: 10.1007/s00259-002-1090-0. Epub 2003 Jan 30. Eur J Nucl Med Mol Imaging. 2003. PMID: 12557049 No abstract available.

10

Radiothérapie et immunothérapie.

Rancoule C, Vallard A, Jmour O, Vial N, Guillaume E, Guy JB, Magné N. Rancoule C, et al. Bull Cancer. 2018 Dec;105 Suppl 1:S92-S100. doi: 10.1016/S0007-4551(18)30394-1. Bull Cancer. 2018. PMID: 30595203 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

1,438 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Search Results

1,438 results

Results by year